ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.771,88
0,00%
S&P 500
5.872,16
-2,95%
US Dollar vs BRL
6,3145
0,38%
Bitcoin
102.194,31
2,13%
Brent Oil
72,98
0,34%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Protalix BioTherapeutics Inc (PLX)

  7. Protalix BioTherapeutics Inc (PLX) Notícias

PLX

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:PLX
DataHoraFonteTítuloCódigoCompanhia
14/11/202409:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
14/11/202408:57Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
05/11/202419:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
25/10/202417:23Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
24/09/202418:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
17/05/202418:05Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:PLXProtalix BioTherapeutics Inc
17/05/202418:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
02/01/202408:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
30/11/202306:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
31/10/202317:40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
15/09/202317:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
06/09/202307:50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
11/08/202317:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
07/07/202317:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
29/06/202308:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202317:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
18/05/202318:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202309:27Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PLXProtalix BioTherapeutics Inc
01/05/202307:48Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202309:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202308:47Edgar (US Regulatory)Annual Report (10-k)AMEX:PLXProtalix BioTherapeutics Inc
03/01/202308:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PLXProtalix BioTherapeutics Inc
14/11/202209:08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PLXProtalix BioTherapeutics Inc
09/09/202218:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PLXProtalix BioTherapeutics Inc
14/07/202217:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PLXProtalix BioTherapeutics Inc
05/07/202217:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PLXProtalix BioTherapeutics Inc
09/06/202215:53Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202207:26Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PLXProtalix BioTherapeutics Inc
20/04/202217:50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:PLXProtalix BioTherapeutics Inc
23/10/202018:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PLXProtalix BioTherapeutics Inc
 Apresentando as notícias mais relevantes sobre:AMEX:PLX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
ATOM3
ATOMPAR ON
BOV
AZUL4
AZUL PN
BOV
AMOB3
Automob Participacoes ON
BOV
BRFS3
BRF S/A ON
BOV
IDIV
Dividend
BOV
BHIA3
Grupo Casas Bahia ON
BOV
BRAV3
Brava Energia ON
BOV
PRIO3
PETRORIO ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
CVCB3
CVC BRASIL ON
BOV
GPIV33
Gp Investments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados